SINO BIOPHARMACEUTICAL-UNADR (SBHMY:OTCMKTS)
$12.68 -0.13 (-1.0148%)
Analysed SINO BIOPHARMACEUTICAL-UNADR (SBHMY:OTCMKTS) News Sources
Weighing Sino Biopharmaceutical (SEHK:1177) After Strong One Year Share Price Run
16-01-2026
yahoo.com
Sanofi bets on Sino Biopharm’s transplant drug in $1.5bn licensing deal
04-03-2026
pharmaceutical-technology.com
GSK cuts deal with Sino to broaden reach of hepatitis B drug
11-05-2026
biopharmadive.com
European Stocks Mixed in Monday Trading; Defense, Luxury Goods Stocks Drop, Mining Shares Rise
11-05-2026
yahoo.com
GSK China Hepatitis B Alliance Puts Bepirovirsen And Valuation In Focus
12-05-2026
yahoo.com
GSK’s Expanded Arexvy Label And Deals Add Context To Valuation Gap
23-05-2026
yahoo.com
GSK plc (GSK) Announces Japan’s Expanded Eligible Population for Arexvy
29-05-2026
yahoo.com
AstraZeneca, GSK intensify China ties with Sino Biopharm deals
08-07-2026
biopharmadive.com
European Stocks Close Sharply Lower in Wednesday Trading; Oil Prices Spike as US-Iran War Reignites
08-07-2026
yahoo.com
Sino and AstraZeneca sign licence agreement for TQC3721
09-07-2026
pharmaceutical-technology.com
What is the current price of SINO BIOPHARMACEUTICAL-UNADR (SBHMY:OTCMKTS)?
The current price of SINO BIOPHARMACEUTICAL-UNADR (SBHMY:OTCMKTS) is $12.68.
SINO BIOPHARMACEUTICAL-UNADR (SBHMY:OTCMKTS) absolute price change since previous trading day?
The absolute price change of SINO BIOPHARMACEUTICAL-UNADR (SBHMY:OTCMKTS) since the previous trading day is $-0.13.
SINO BIOPHARMACEUTICAL-UNADR (SBHMY:OTCMKTS) percentage price change since previous trading day?
The percentage price change of SINO BIOPHARMACEUTICAL-UNADR (SBHMY:OTCMKTS) since the previous trading day is -1.0148%.
What is the most recent average sentiment score for SINO BIOPHARMACEUTICAL-UNADR (SBHMY:OTCMKTS)?
The most recent average sentiment score for SINO BIOPHARMACEUTICAL-UNADR (SBHMY:OTCMKTS) is 56 out of 100.
What is the most recent average sentiment for SINO BIOPHARMACEUTICAL-UNADR (SBHMY:OTCMKTS)?
The most recent sentiment for SINO BIOPHARMACEUTICAL-UNADR (SBHMY:OTCMKTS) is .
SEC-8K** Filing Available For SINO BIOPHARMACEUTICAL-UNADR (SBHMY:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.